RE:RE:RE:RE:The other side of the pandemic I would make the argument that you don't even need travel to be back at record levels or even pre-pandemic levels for CHR to keep rising. The valuation is just too low and they produce significant cash right now.
As long as they just produce mediocre results (which they're not - just stating pessmistic scenario) - we're still looking at another 20% or so increase in share price.